2016 Annual ALS Surveillance Meeting executive summary, August 3-4, 2016
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
Clear All

2016 Annual ALS Surveillance Meeting executive summary, August 3-4, 2016

  • Published Date:


  • Language:
Filetype[PDF-79.63 KB]

  • Description:
    Due to the limited information on the unknown cause(s) of Amyotrophic Lateral Sclerosis (ALS), the Agency for Toxic Substances and Disease Registry (ATSDR) established the National ALS Registry in 2010. The primary purpose of the ALS Registry is to estimate the incidence and prevalence of ALS, describe the demographics of persons with ALS (PALS), and examine the risk factors for the disease. On August 5, 2016, the National ALS Registry published their second report on the prevalence of ALS in the United States in CDC’s Morbidity and Mortality Weekly Report (MMWR). ATSDR organizes the Annual ALS Surveillance Meeting to update stakeholders on the progress of the National ALS Registry, discuss the uses of Registry data, and to explore strategies to further enhance the Registry for all stakeholders. In late 2016, the Registry will launch the National ALS Biorepository with the primary goal of providing scientists access to the largest bank of bio samples in the US (e.g., blood, urine, tissue) for research. Publication date from document properties.
  • Document Type:
  • Main Document Checksum:
  • File Type:
  • Supporting Files:
    No Additional Files
No Related Documents.

You May Also Like: